Story perspectives
TrumpRx Proposal Aims to Disrupt Prescription Drug Market
9/23/2025
23 4
1 of 1
Story summary
- The Trump administration is weighing TrumpRx to sell prescription medicines directly to consumers, challenging pharmacies and platforms.
- Patients could search for medications and connect with sellers, potentially lowering prices.
- Discussions head toward a Sept. 29 deadline for drug companies, with potential hits to pharmacy revenues.
- Health Secretary Robert F. Kennedy Jr. is expected to claim Tylenol autism; researchers criticize.
